TOVX
NYSE MKT
$0.23
Theriva Biologics Inc (TOVX)
Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. The company is headquartered in Rockville, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Target: $2.50 (+991.70%)
Market Cap
$11M
P/B Ratio
0.72
Price Chart
Valuation
Market Cap$11M
P/S37.16
P/B0.72
Profitability
Total Revenue (TTM)$300K
Gross Profit (TTM)$300K
EBITDA-$22M
Operating Margin-709%
EPS-$1.97
Growth & Risk
EPS 5Y CAGR-21.74%
FCF 5Y CAGR+6.41%
Sharpe Ratio0.22